FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Cresemba (isavuconazonium sulfate) filed by Astellas Pharma US, expanding its approved use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis
• Mucormycosis

Drugs mentioned

• Cresemba (isavuconazole)

Snippet

SUPPL AP for CRESEMBA (ISAVUCONAZONIUM SULFATE)